Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,095 recruiting studies in this area right now.
By phase
- Not applicable4,200
- Phase 2594
- Phase 1413
- Phase 3325
- Phase 4252
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer337
- Cervical Cancer224
- Endometrial Cancer209
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer112
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California350
- Alabama153
- Texas120
- Massachusetts117
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,095 total
- NCT06646627RecruitingPhase 1
B7-H3 car t cells for platinum-resistant ovarian cancer
This trial tests a new treatment where your own immune cells are modified to attack ovarian cancer cells that have stopped responding to platinum chemotherapy. It's for people with recurrent ovarian cancer that hasn't gotten better with standard treatments.
Palo Alto, CaliforniaAges 18 years+ - NCT06654011RecruitingPhase 2
A study testing a new combination for rare cervical cancer
This trial tests whether adding the drug IN10018 to a standard chemotherapy and immunotherapy combination can help treat a rare type of cervical cancer called gastric-type adenocarcinoma that has spread or come back. The goal is to see if this combination improves outcomes for patients who have already had at least one round of chemotherapy.
Wuhan, HubeiAges 18–75 - NCT06646250Recruiting
New ultrasound for steady brain monitoring in newborns
This trial uses a new ultrasound device (NeoDoppler) to watch blood flow in a baby's brain continuously. It aims to see if this gentle, bedside tool can help doctors monitor babies—especially those born early or with certain health concerns—without moving them.
TrondheimAges birth–1 year - NCT06646653RecruitingPhase 3
Alma system for postpartum bleeding after childbirth
This trial tests a device called Alma to treat heavy bleeding after childbirth when standard medicines and massage haven't worked. It's for women who have lost a moderate amount of blood within 24 hours of delivery, either vaginally or by C-section.
Brooklyn, New YorkAges 18 years+ - NCT06648174Recruiting
Managing heart health risk after gestational diabetes
This study tests a program to help women who had gestational diabetes reduce their future risk of heart disease and diabetes. It checks if monitoring and support can improve health after pregnancy.
HsinchuAges 18 years+ - NCT06653738RecruitingPhase 3
Testing empagliflozin and diet advice for kidney stone prevention
This trial tests if a medication called empagliflozin, combined with personalized diet advice, can help prevent kidney stones from coming back. It may be an option if you've had two or more kidney stone events in the last 10 years and your stones were mostly calcium-based.
AmiensAges 18 years+ - NCT06646185Recruiting
Improving menstrual and vaginal health for women
This study looks at menstrual and vaginal health in women aged 18 to 35. It aims to understand normal cycles and find ways to improve health for all.
Yaoundé, YaoundéAges 18–35 - NCT06647511Recruiting
Digital health study for pregnant refugees in NYC
This study tests a smartphone-based tool to help pregnant refugees and asylum seekers stay healthy during pregnancy. It aims to reduce complications and improve care for mothers and babies.
New York, New YorkAges 18 years+ - NCT06652113Recruiting
Hydroxychloroquine with thyroid hormone for recurrent pregnancy loss
This study tests whether a combination of hydroxychloroquine (an anti-inflammatory drug) and levothyroxine (thyroid hormone) can improve live birth rates in women with recurrent pregnancy loss, normal thyroid function, and TPO antibodies.
Guangzhou, GuangdongAges 20–40 - NCT06653426Recruiting
The effect of NaBu on menstrual symptoms
This study tests whether taking a supplement called NaBu can help reduce menstrual symptoms. It may be an option if you have bothersome period symptoms like cramps or bloating.
Chicago, IllinoisAges 18 years+ - NCT06186271Recruiting
Safety of Estetrol Birth Control Pill Study
This study checks the safety of a newer birth control pill (E4/DRSP) compared to other common pills. It is for women who are just starting one of these pills.
Berlin, State of BerlinAges Any age - NCT06644846Recruiting
Spaced radiation for gynecologic cancers
This trial tests a special type of radiation that is given in small, spaced-out beams to treat gynecologic cancers (like cervical or uterine cancer). It is for patients who cannot get standard internal radiation (brachytherapy) because of unusual anatomy, large tumors, a narrow vagina, or anesthesia risks.
Navi Mumbai, MaharashtraAges 18–70 - NCT06644755RecruitingPhase 1
First-in-human study of DS-2243a for advanced cancers
This trial tests a new drug called DS-2243a for people with advanced solid tumors that have stopped responding to standard treatments. It targets a specific protein found in some cancers, and you need to have a particular immune system marker for it to work.
Boston, MassachusettsAges 18 years+ - NCT06637423RecruitingPhase 1/Phase 2
Study of sacituzumab tirumotecan for low-grade bladder cancer
This trial tests a new drug called sacituzumab tirumotecan for people with low-grade bladder cancer that hasn't spread into the bladder muscle. The goal is to see if it can help shrink or control the tumors.
Bakersfield, CaliforniaAges 18 years+ - NCT06643741Recruiting
Preeclampsia screening study for pregnant women
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
Glendale, ArizonaAges 18 years+ - NCT06635889RecruitingPhase 2
Numbing medicine in bladder after kidney stone surgery
This study tests whether numbing medicine placed directly into the bladder can reduce pain after a ureteroscopy procedure for kidney stones. It may help you feel better and use less pain medication after surgery.
Chicago, IllinoisAges 18 years+ - NCT06639191RecruitingEarly Phase 1
Study of a new drug for cancers expressing CD44v6
This trial tests a new radioactive drug called [177Lu]Lu-AKIR001 for patients with certain advanced cancers (like thyroid, head and neck, lung, vulvar, or cervical cancer) that have a specific protein called CD44v6 on their surface. The goal is to see if this treatment can help when standard options have stopped working.
Stockholm, Stockholm CountyAges 18 years+ - NCT06634355Enrolling by invitation
Testing how sugammadex crosses the placenta
This study uses donated placentas to see if sugammadex, a drug used to reverse anesthesia, can pass from mother to baby. The results may help guide safer anesthesia use in pregnant women.
Leuven, Vlaams-BrabantAges 18–45 - NCT06638463Recruiting
My Health Coach App Study
This trial tests whether the My Health Coach app can help adults with fetal alcohol spectrum disorder or prenatal alcohol exposure. It is for people who own a smartphone and can read English.
Rochester, New YorkAges 18 years+ - NCT06636149Recruiting
Position changes during slow labor
This study tests if changing the mother's position during a long, slow labor can help speed things up. If your labor is not progressing as expected, you may be able to join and try different positions to see if they help.
Saint Loius, MissouriAges 12 years+ - NCT06641141Recruiting
Wait or induce at 38 weeks for gestational diabetes
This trial compares two approaches for people with gestational diabetes: waiting for labor to start naturally versus inducing labor at 38 weeks. The goal is to see if one plan leads to better outcomes for both mother and baby.
Ottawa, OntarioAges 16 years+ - NCT06643598Recruiting
Virtual and lived-experience support for newborns with brain challenges
This study tests whether a program that combines virtual support and a peer who has been through it can help parents of newborns with certain brain conditions. It is designed for families living in rural areas and aims to improve children's recovery.
Madison, WisconsinAges Up to 5 years - NCT06642402Recruiting
Studying lupus kidney disease using urine particles
This study looks at tiny particles in urine to better understand and monitor lupus-related kidney problems. It may help find better ways to track the disease without invasive biopsies.
KoldingAges 18 years+ - NCT06642649Recruiting
Comparing anesthesia types to reduce opioids in hysterectomy
This study compares general anesthesia alone to two types of combined anesthesia (general plus spinal) to see which reduces the amount of opioid painkillers needed during and after a laparoscopic hysterectomy. It may help patients recover with less reliance on strong pain medications.
Bellinzona, SwitzerlandAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,095 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,917 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.